A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
Clinical trial NCT06625541 · COMPLETED
Trial details
- NCT number
- NCT06625541
- Sponsor
- AnnJi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2025-08-15
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.